Suppr超能文献

万古霉素与不同抗生素对大肠杆菌的协同相互作用:甲氧苄啶和呋喃妥因与万古霉素联合对野生型大肠杆菌显示出很强的协同作用。

Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli.

作者信息

Zhou Alice, Kang Tina Manzhu, Yuan Jessica, Beppler Casey, Nguyen Caroline, Mao Zhiyuan, Nguyen Minh Quan, Yeh Pamela, Miller Jeffrey H

机构信息

Department of Microbiology, Immunology, and Molecular Genetics, the Molecular Biology Institute, and the David Geffen School of Medicine, University of California, Los Angeles, California, USA.

Department of Ecology and Evolutionary Biology, University of California, Los Angeles, California, USA

出版信息

Antimicrob Agents Chemother. 2015 Jan;59(1):276-81. doi: 10.1128/AAC.03502-14. Epub 2014 Oct 27.

Abstract

Gram-negative bacteria are normally resistant to the antibiotic vancomycin (VAN), which cannot significantly penetrate the outer membrane. We used Escherichia coli mutants that are partially sensitive to VAN to study synergies between VAN and 10 other antibiotics representing six different functional categories. We detected strong synergies with VAN and nitrofurantoin (NTR) and with VAN and trimethoprim (TMP) and moderate synergies with other drugs, such as aminoglycosides. These synergies are powerful enough to show the activity of VAN against wild-type E. coli at concentrations of VAN as low as 6.25 μg/ml. This suggests that a very small percentage of exogenous VAN does enter E. coli but normally has insignificant effects on growth inhibition or cell killing. We used the results of pairwise interactions with VAN and the other 10 antibiotics tested to place VAN into a functional category of its own, as previously defined by Yeh et al. (P. Yeh, A. I. Tschumi, and R. Kishony, Nat Genet 28:489-494, 2006, http://dx.doi.org/10.1038/ng1755).

摘要

革兰氏阴性菌通常对抗生素万古霉素(VAN)具有抗性,因为万古霉素无法有效穿透其外膜。我们使用了对万古霉素部分敏感的大肠杆菌突变体,来研究万古霉素与代表六种不同功能类别的其他10种抗生素之间的协同作用。我们检测到万古霉素与呋喃妥因(NTR)以及万古霉素与甲氧苄啶(TMP)之间有很强的协同作用,与其他药物如氨基糖苷类有中等程度的协同作用。这些协同作用强大到足以在万古霉素浓度低至6.25μg/ml时显示出其对野生型大肠杆菌的活性。这表明极少量的外源性万古霉素确实能进入大肠杆菌,但通常对生长抑制或细胞杀伤作用不显著。我们利用万古霉素与其他10种测试抗生素的成对相互作用结果,将万古霉素归入Yeh等人(P. Yeh、A. I. Tschumi和R. Kishony,《自然遗传学》28:489 - 494,2006,http://dx.doi.org/10.1038/ng1755)先前定义的一个独立功能类别中。

相似文献

2
Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1515-20. doi: 10.1128/AAC.02485-15.
4
Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Clin Infect Dis. 2003 Jan 15;36(2):183-7. doi: 10.1086/345754. Epub 2003 Jan 3.
6
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
J Antimicrob Chemother. 2014 Dec;69(12):3259-62. doi: 10.1093/jac/dku282. Epub 2014 Jul 25.
7
Cold Stress Makes Escherichia coli Susceptible to Glycopeptide Antibiotics by Altering Outer Membrane Integrity.
Cell Chem Biol. 2016 Feb 18;23(2):267-277. doi: 10.1016/j.chembiol.2015.12.011. Epub 2016 Feb 4.
8
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
J Antimicrob Chemother. 2008 Sep;62(3):495-503. doi: 10.1093/jac/dkn222. Epub 2008 Jun 10.
9
The Antibiotic Trimethoprim Displays Strong Mutagenic Synergy with 2-Aminopurine.
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01577-18. Print 2019 Feb.

引用本文的文献

1
Multiplexed bacteriocin synthesis to combat and prevent antimicrobial resistance.
Commun Biol. 2025 Aug 19;8(1):1246. doi: 10.1038/s42003-025-08639-y.
3
Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria.
ACS Infect Dis. 2025 Feb 14;11(2):323-334. doi: 10.1021/acsinfecdis.4c00702. Epub 2025 Jan 24.
4
Biocompatible antibiotic-coupled nickel-titanium nanoparticles as a potential coating material for biomedical devices.
Heliyon. 2024 May 18;10(10):e31434. doi: 10.1016/j.heliyon.2024.e31434. eCollection 2024 May 30.
6
Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review.
Front Cell Infect Microbiol. 2023 Jul 27;13:1148603. doi: 10.3389/fcimb.2023.1148603. eCollection 2023.
7
Natural flavonoids disrupt bacterial iron homeostasis to potentiate colistin efficacy.
Sci Adv. 2023 Jun 9;9(23):eadg4205. doi: 10.1126/sciadv.adg4205.
8
Identification of a small molecule 0390 as a potent antimicrobial agent to combat antibiotic-resistant .
Front Microbiol. 2022 Dec 15;13:1078318. doi: 10.3389/fmicb.2022.1078318. eCollection 2022.
9
Inhibition of MurA Enzyme from and by Diterpenes from and Their Synthetic Analogs.
Antibiotics (Basel). 2021 Dec 15;10(12):1535. doi: 10.3390/antibiotics10121535.
10
Uncovering Key Metabolic Determinants of the Drug Interactions Between Trimethoprim and Erythromycin in .
Front Microbiol. 2021 Oct 20;12:760017. doi: 10.3389/fmicb.2021.760017. eCollection 2021.

本文引用的文献

1
Unraveling the physiological complexities of antibiotic lethality.
Annu Rev Pharmacol Toxicol. 2015;55:313-32. doi: 10.1146/annurev-pharmtox-010814-124712. Epub 2014 Sep 10.
4
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.
Nat Med. 2014 Feb;20(2):152-158. doi: 10.1038/nm.3458. Epub 2014 Jan 26.
5
7
Activated ClpP kills persisters and eradicates a chronic biofilm infection.
Nature. 2013 Nov 21;503(7476):365-70. doi: 10.1038/nature12790. Epub 2013 Nov 13.
8
Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway.
Science. 2013 Jun 28;340(6140):1583-7. doi: 10.1126/science.1238328.
9
Silver enhances antibiotic activity against gram-negative bacteria.
Sci Transl Med. 2013 Jun 19;5(190):190ra81. doi: 10.1126/scitranslmed.3006276.
10
Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.
Angew Chem Int Ed Engl. 2013 Jul 22;52(30):7822-4. doi: 10.1002/anie.201302749. Epub 2013 Jun 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验